Latest news with #EmmanuelRupert
Time of India
a day ago
- Health
- Time of India
Hospital launches advanced 3D mammography system
New Delhi: Dharamshila Narayana Superspeciality Hospital launched an advanced 3D mammography system on Thursday to commemorate the Cancer Survivor Month. During the inauguration ceremony, attended by chief minister Rekha Gupta as the chief guest, the hospital launched a comprehensive free women's health cancer screening programme and implemented the Ayushman Bharat scheme . The newly installed 3D mammography equipment provides accurate, efficient breast screenings with minimal radiation exposure. This technology enables early detection of abnormalities, making cancer screening accessible to women across economic sections, thereby reducing instances of late-stage breast cancer diagnoses. During the mammography unit launch, the chief minister said that "this unit is specially designed for the early detection of breast cancer in women, enabling timely treatment. Equipped with fully digital technology, the unit ensures quick and accurate diagnosis using the latest medical equipment." She added that "cancer is a disease that causes emotional turmoil for entire families when it strikes. However, advancements in medical science today have made early detection and effective treatment possible." Speaking at the event, Dr Emmanuel Rupert, managing director and Group CEO of Narayana Health, explained the significance of the new initiatives. He outlined the screening programme offering 5,000 free pap smear tests and 5,000 free mammography screenings, alongside clinical breast examinations, cervical cancer screening, and lifestyle counselling for underprivileged women and Ayushman Bharat beneficiaries. He also mentioned the introduction of a mobile diagnostic unit providing mammograms and laboratory tests to underserved areas in Delhi.
Time of India
2 days ago
- Health
- Time of India
Hospital launches advanced 3D mammography system
New Delhi: Dharamshila Narayana Superspeciality Hospital launched an advanced 3D mammography system on Thursday to commemorate the Cancer Survivor Month. During the inauguration ceremony, attended by chief minister Rekha Gupta as the chief guest, the hospital launched a comprehensive free women's health cancer screening programme and implemented the Ayushman Bharat scheme. The newly installed 3D mammography equipment provides accurate, efficient breast screenings with minimal radiation exposure. This technology enables early detection of abnormalities, making cancer screening accessible to women across economic sections, thereby reducing instances of late-stage breast cancer diagnoses. During the mammography unit launch, the chief minister said that "this unit is specially designed for the early detection of breast cancer in women, enabling timely treatment. Equipped with fully digital technology, the unit ensures quick and accurate diagnosis using the latest medical equipment." She added that "cancer is a disease that causes emotional turmoil for entire families when it strikes. However, advancements in medical science today have made early detection and effective treatment possible. " Speaking at the event, Dr Emmanuel Rupert, managing director and Group CEO of Narayana Health, explained the significance of the new initiatives. He outlined the screening programme offering 5,000 free pap smear tests and 5,000 free mammography screenings, alongside clinical breast examinations, cervical cancer screening, and lifestyle counselling for underprivileged women and Ayushman Bharat beneficiaries. He also mentioned the introduction of a mobile diagnostic unit providing mammograms and laboratory tests to underserved areas in Delhi. TNN Follow more information on Air India plane crash in Ahmedabad here . Get real-time live updates on rescue operations and check full list of passengers onboard AI 171 .
Business Standard
26-05-2025
- Business
- Business Standard
Narayana Hrudayalaya surges after Q4 PAT rises 3% YoY to Rs 197 cr
Narayana Hrudayalaya rallied 8.44% to Rs 1,870 after the company reported a 3.41% rise in consolidated net profit to Rs 197.21 crore on an 18.39% increase in revenue from operations to Rs 1,475.44 crore in Q4 FY25 over Q4 FY24. Profit before tax stood at Rs 253.02 crore during the quarter, registering a growth of 13.86% from Rs 222.22 crore reported in Q4 FY24. India's revenue stood at Rs 1,108.8 crore, up 10.66% year-on-year (YoY), while revenue from the Cayman Islands was Rs 379.7 crore, up 50.2% YoY. Consolidated EBITDA grew by 22.17% to Rs 384.6 crore in the March 2025 quarter from Rs 314.8 crore in Q4 FY24. EBITDA margin improved to 26.1% in Q4 FY25 as against 25.3% in Q4 FY24. On the margins front, the company's operating margin reduced to 24.25% in Q4 FY25, compared with 23.02% recorded in Q4 FY24. Net profit margin declined to 13.30% in Q4 FY25 from 14.91% registered in Q4 FY24. As of March 31, 2025, the companys total borrowings, net of cash, bank balances, and current investments, stood at Rs 533 crore. The net debt-to-equity ratio was at 0.15, with foreign currency-denominated debt amounting to $86.8 million. On a full-year basis, the company's net profit rose 0.11% to Rs 790.16 crore on a 12.12% rise in revenue to Rs 5,482.98 crore in FY25 over FY24. Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said, The current financial year demonstrated strong performance across our units, both domestic and international; we are pleased to report the highest-ever revenues and profitability margins on both a quarterly and an annual basis at the consolidated level. The performance improvement in India units has been driven by domestic volume pickup, increased realizations, and optimization in payor categories. While our flagships continue to contribute significantly, our Southern Peripheral and North units have shown significant growth this year, and we hope to build on the momentum going forward. The new hospital in Camana Bay is fully functional and is contributing meaningfully to the overall Cayman business. We are excited about the traction in the new hospital and are confident that the region will deliver strong growth going forward. The integrated care business is picking up well, with our new clinics garnering sizeable footfalls. We will continue to invest in this business and are optimistic that it will be a significant driver of growth for the overall NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the upcoming year. Meanwhile, the board has recommended a final dividend of Rs 4.50 per equity share for the financial year ended March 31, 2025. The record date for determining eligible shareholders has been set as Friday, 1 August 2025. Additionally, the board approved a proposal to seek shareholder approval via special resolution to raise up to Rs 1,500 crore in a financial year through the issuance of debt securities, including non-convertible debentures (NCDs), in one or more tranches on a private placement basis. The securities may be denominated in Indian rupees or foreign currency. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 2 heart centers across India, along with an overseas presence in the Cayman Islands, with over 5,550 operational beds and a capacity of over 5,900 beds.
Business Standard
24-05-2025
- Business
- Business Standard
Narayana Hrudayalaya Q4 PAT grows 3% YoY to Rs 197 cr
Narayana Hrudayalaya reported a 3.41% rise in consolidated net profit to Rs 197.21 crore on an 18.39% increase in revenue from operations to Rs 1,475.44 crore in Q4 FY25 over Q4 FY24. Profit before tax stood at Rs 253.02 crore during the quarter, registering a growth of 13.86% from Rs 222.22 crore reported in Q4 FY24. India's revenue stood at Rs 1,108.8 crore, up 10.66% year-on-year (YoY), while revenue from the Cayman Islands was Rs 379.7 crore, up 50.2% YoY. Consolidated EBITDA grew by 22.17% to Rs 384.6 crore in the March 2025 quarter from Rs 314.8 crore in Q4 FY24. EBITDA margin improved to 26.1% in Q4 FY25 as against 25.3% in Q4 FY24. On the margins front, the company's operating margin reduced to 24.25% in Q4 FY25, compared with 23.02% recorded in Q4 FY24. Net profit margin declined to 13.30% in Q4 FY25 from 14.91% registered in Q4 FY24. As of March 31, 2025, the companys total borrowings, net of cash, bank balances, and current investments, stood at Rs 533 crore. The net debt-to-equity ratio was at 0.15, with foreign currency-denominated debt amounting to $86.8 million. On a full-year basis, the company's net profit rose 0.11% to Rs 790.16 crore on a 12.12% rise in revenue to Rs 5,482.98 crore in FY25 over FY24. Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said, The current financial year demonstrated strong performance across our units, both domestic and international; we are pleased to report the highest-ever revenues and profitability margins on both a quarterly and an annual basis at the consolidated level. The performance improvement in India units has been driven by domestic volume pickup, increased realizations, and optimization in payor categories. While our flagships continue to contribute significantly, our Southern Peripheral and North units have shown significant growth this year, and we hope to build on the momentum going forward. The new hospital in Camana Bay is fully functional and is contributing meaningfully to the overall Cayman business. We are excited about the traction in the new hospital and are confident that the region will deliver strong growth going forward. The integrated care business is picking up well, with our new clinics garnering sizeable footfalls. We will continue to invest in this business and are optimistic that it will be a significant driver of growth for the overall NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the upcoming year. Meanwhile, the board has recommended a final dividend of Rs 4.50 per equity share for the financial year ended March 31, 2025. The record date for determining eligible shareholders has been set as Friday, 1 August 2025. Additionally, the board approved a proposal to seek shareholder approval via special resolution to raise up to Rs 1,500 crore in a financial year through the issuance of debt securities, including non-convertible debentures (NCDs), in one or more tranches on a private placement basis. The securities may be denominated in Indian rupees or foreign currency. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 2 heart centers across India, along with an overseas presence in the Cayman Islands, with over 5,550 operational beds and a capacity of over 5,900 beds. Shares of Narayana Hrudayalaya rose 0.01% to end at Rs 1,724.40 on Friday, 23 May 2025.
